AKT1 and COVID-19: Given that PI3K/AKT is important in both COVID-19 and neurodegenerative diseases, modulation of this pathway in specific cell types could present a relevant option for treatment of neurodegenerative diseases (Chu et al., 2021; Razani et al., 2021) and could open a window of opportunity to avoid neurodegenerative sequelae of COVID-19.